The lower oesophageal sphincter

Neurogastroenterology and Motility

Volumn 17, Issue SUPPL. 1, 2005, Pages 13-21

  Boeckxstaens, G E ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Gastro oesophageal reflux disease; Lower oesophageal sphincter; Transient lower oesophageal sphincter relaxation

Indexed keywords

NEUROTRANSMITTER; NITRIC OXIDE;

BARRETT ESOPHAGUS; DIAPHRAGM; DISEASE SEVERITY; DYSPHAGIA; ESOPHAGUS ACHALASIA; ESOPHAGUS CARCINOMA; EXPOSURE; FOOD INTAKE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; INNERVATION; LOWER ESOPHAGUS SPHINCTER; MUSCLE REFLEX; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW; STOMACH ACID; STOMACH CONTENT; SWALLOWING; SYMPTOMATOLOGY;

ANIMALS; ESOPHAGEAL ACHALASIA; ESOPHAGEAL SPHINCTER, LOWER; GASTROESOPHAGEAL REFLUX; HUMANS;

EID: 19944403902     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2005.00661.x     Document Type: Review

References (96)

1. Mittal RK, Balaban DH. The esophagogastric junction. N Engl J Med 1997; 336: 924-32.
2. Hornby PJ, Abrahams TP, Partosoedarso ER. Central mechanisms of lower esophageal sphincter control. Gastroenterol Clin North Am 2002; 31(Suppl. 4): S11-S20.
3. Goyal RK, Padmanabhan R, Sang Q. Neural circuits in swallowing and abdominal vagal afferent-mediated lower esophageal sphincter relaxation. Am J Med 2001; 111(Suppl. 8A): 95S-105S.
4. Collman PI, Tremblay L, Diamant NE. The distribution of spinal and vagal sensory neurons that innervate the esophagus of the cat. Gastroenterology 1992; 103: 817-22.
5. Hyland NP, Abrahams TP, Fuchs K et al. Organization and neurochemistry of vagal preganglionic neurons innervating the lower esophageal sphincter in ferrets. J Comp Neurol 2001; 430: 222-34.
6. Rogers RC, Hermann GE, Travagli RA. Brainstem pathways responsible for oesophageal control of gastric motility and tone in the rat. J Physiol 1999; 514(Pt 2): 369-83.
7. Yuan S, Costa M, Brookes SJ. Neuronal pathways and transmission to the lower esophageal sphincter of the guinea pig. Gastroenterology 1998; 115: 661-71.
8. Paterson WG, Anderson MA, Anand N. Pharmacological characterization of lower esophageal sphincter relaxation induced by swallowing, vagal efferent nerve stimulation, and esophageal distention. Can J Physiol Pharmacol 1992; 70: 1011-5.
9. Sivarao DV, Mashimo HL, Thatte HS et al. Lower esophageal sphincter is achalasic in nNOS(-/-) and hypotensive in W/W(v) mutant mice. Gastroenterology 2001; 121: 34-42.
10. Yamato S, Saha JK, Goyal RK. Role of nitric oxide in lower esophageal sphincter relaxation to swallowing. Life Sci 1992; 50: 1263-72.
11. Blackshaw LA, Haupt JA, Omari T et al. Vagal and sympathetic influences on the ferret lower oesophageal sphincter. J Auton Nerv Syst 1997; 66: 179-88.
12. Kawahara H, Blackshaw LA, Lehmann A et al. Responses of the rat lower oesophageal sphincter (LOS) to vagal efferent activation. Neurogastroenterol Motil 1997; 9: 85-97.
13. De Man JG, Pelckmans PA, Boeckxstaens GE et al. The role of nitric oxide in inhibitory non-adrenergic non-cholinergic neurotransmission in the canine lower oesophageal sphincter. Br J Pharmacol 1991; 103: 1092-6.
14. Tottrup A, Svane D, Forman A. Nitric oxide mediating NANC inhibition in opossum lower esophageal sphincter, Am J Physiol 1991; 260(3 Pt 1): G385-9.
15. Conklin JL, Du C, Murray JA et al. Characterization and mediation of inhibitory junction potentials from opossum lower esophageal sphincter. Gastroenterology 1993; 104: 1439-44.
16. Park H, Clark E, Conklin JL. Effects of phosphodiesterase inhibitors on oesophageal neuromuscular functions. Neurogastroenterol Motil 2003; 15: 625-33.
17. Uc A, Oh ST, Murray JA et al. Biphasic relaxation of the opossum lower esophageal sphincter: roles of NO, VIP, and CGRP. Am J Physiol 1999; 277(3 Pt 1): G548-54.
18. Preiksaitis HG, Tremblay L, Diamant NE. Nitric oxide mediates inhibitory nerve effects in human esophagus and lower esophageal sphincter. Dig Dis Sci 1994; 39: 770-5.
19. Tottrup A, Ny L, Alm P et al. The role of the L-arginine/ nitric oxide pathway for relaxation of the human lower oesophageal sphincter. Acta Physiol Scand 1993; 149: 451-9.
20. Murray JA, Ledlow A, Launspach J et al. The effects of recombinant human hemoglobin on esophageal motor functions in humans. Gastroenterology 1995; 109: 1241-8.
21. Hirsch DP, Tiel-Van Buul MM, Tytgat GN et al. Effect of L-NMMA on postprandial transient lower esophageal sphincter relaxations in healthy volunteers. Dig Dis Sci 2000; 45: 2069-75.
22. Richter JE, Wu WC, Johns DN et al. Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of 'abnormal' contractions. Dig Dis Sci 1987; 32: 583-92.
23. Schoeman MN, Tippett MD, Akkermans LM et al. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology 1995; 108: 83-91.
24. Zhang Y, Paterson WG. Role of sarcoplasmic reticulum in control of membrane potential and nitrergic response in opossum lower esophageal sphincter. Br J Pharmacol 2003; 140: 1097-107.
25. Salapatek AM, Ji J, Diamant NE. Ion channel diversity in the feline smooth muscle esophagus. Am J Physiol 2002; 282: G288-99.
26. Dodds WJ, Dent J, Hogan WJ et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982; 307: 1547-52.
27. Mittal RK, Rochester DF, McCallum RW. Sphincteric action of the diaphragm during a relaxed lower esophageal sphincter in humans. Am J Physiol 1989; 256(1 Pt 1): G139-44.
28. Mittal RK. The crural diaphragm, an external lower esophageal sphincter: a definitive study. Gastroenterology 1993; 105: 1565-7.
29. Mittal RK, Fisher M, McCallum RW et al. Human lower esophageal sphincter pressure response to increased intra-abdominal pressure. Am J Physiol 1990; 258(4 Pt 1): G624-30.
30. Mittal RK, Fisher MJ. Electrical and mechanical inhibition of the crural diaphragm during transient relaxation of the lower esophageal sphincter. Gastroenterology 1990; 99: 1265-8.
31. Mittal RK, Chiareli C, Liu J et al. Characteristics of lower esophageal sphincter relaxation induced by pharyngeal stimulation with minute amounts of water. Gastroenterology 1996; 111: 378-84.
32. Kahrilas PJ, Lin S, Chen J et al. The effect of hiatus hernia on gastro-oesophageal junction pressure. Gut 1999; 44: 476-82.
33. Jean A. Brain stem control of swallowing: neuronal network and cellular mechanisms. Physiol Rev 2001; 81: 929-69.
34. Sang Q, Goyal RK. Swallowing reflex and brain stem neurons activated by superior laryngeal nerve stimulation in the mouse. Am J Physiol 2001; 280: G191-200.
35. Sang Q, Goyal RK. Lower esophageal sphincter relaxation and activation of medullary neurons by subdiaphragmatic vagal stimulation in the mouse. Gastroenterology 2000; 119: 1600-9.
36. Mittal RK, McCallum RW. Characteristics of transient lower esophageal sphincter relaxation in humans. Am J Physiol 1987; 252(5 Pt 1): G636-41.
37. Hirsch DP, Tytgat GN, Boeckxstaens GE. Transient lower oesophageal sphincter relaxations-a pharmacological target for gastro-oesophageal reflux disease? Aliment Pharmacol Ther 2002; 16: 17-26.
38. Martin CJ, Patrikios J, Dent J. Abolition of gas reflux and transient lower esophageal sphincter relaxation by vagal blockade in the dog. Gastroentemlogy 1986; 91: 890-6.
39. Hirano I, Tatum RP, Shi G et al. Manometric heterogeneity in patients with idiopathic achalasia. Gastroenterology 2001; 120: 789-98.
40. Richter JE. Oesophageal motility disorders. Lancet 2001; 358: 823-8.
41. Vantrappen G, Hellemans J, Deloof W et al. Treatment of achalasia with pneumatic dilatations. Gut 1971; 12: 268-75.
42. Howard PJ, Maher L, Pryde A et al. Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut 1992; 33: 1011-5.
43. Paterson WG. Etiology and pathogenesis of achalasia. Gastiointest Endosc Clin N Am 2001; 11: 249-66, vi.
44. Mearin F, Mourelle M, Guarner F et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest 1993; 23: 724-8.
45. Clark SB, Rice TW, Tubbs RR et al. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol 2000; 24: 1153-8.
46. Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996; 111: 648-54.
47. Storch WB, Eckardt VF, Junginger T. Complement components and terminal complement complex in oesophageal smooth muscle of patients with achalasia. Cell Mol Biol (Noisy-le-grand) 2002; 48: 247-52.
48. Storch WB, Eckardt VF, Wienbeck M et al. Autoantibodies to Auerbach's plexus in achalasia. Cell Mol Biol (Noisy-le-grand) 1995; 41: 1033-8.
49. Moses PL, Ellis LM, Anees MR et al. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut 2003; 52: 629-36.
50. Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci 2002; 47: 15-9.
51. Robertson CS, Martin BA, Atkinson M. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut 1993; 34: 299-302.
52. Castagliuolo I, Brun P, Costantini M et al. Esophageal achalasia: is the herpes simplex virus really innocent? J Gastiointest Surg 2004; 8: 24-30.
53. Birgisson S, Galinski MS, Goldblum JR et al. Achalasia is not associated with measles or known herpes and human papilloma viruses. Dig Dis Sci 1997; 42: 300-6.
54. Tottrup A, Forman A, Funch-Jensen P et al. Effects of postganglionic nerve stimulation in oesophageal achalasia: an in vitro study. Gut 1990; 31: 17-20.
55. Boeckxstaens GE, Mebis J, Janssens J et al. Clinical relevance of nitric oxide in the gut. Lancet 1994; 344: 129.
56. Dodds WJ, Dent J, Hogan WJ et al. Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology 1981; 80: 327-33.
57. Paterson WG. Esophageal and lower esophageal sphincter response to balloon distention in patients with achalasia. Dig Dis Sci 1997; 42: 106-12.
58. Holloway RH, Wyman JB, Dent j. Failure of transient lower oesophageal sphincter relaxation in response to gastric distension in patients with achalasia: evidence for neural mediation of transient lower oesophageal sphincter relaxations. Gut 1989; 30: 762-7.
59. Vakil N, Kadakia S, Eckardt VF. Pneumatic dilation in achalasia. Endoscopy 2003; 35: 526-30.
60. West RL, Hirsch DP, Bartelsman JF et al. Long term results of pneumatic dilation in achalasia followed for more than 5 years. Am J Gastroenterol 2002; 97: 1346-51.
61. Zaninotto G, Annese V, Costantini M et al. Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia. Ann Surg 2004; 239: 364-70.
62. Zaninotto G, Costantini M, Molena D et al. Minimally invasive surgery for esophageal achalasia. J Laparoendosc Adv Surg Tech A 2001; 11: 351-9.
63. Vaezi MF, Richter JE, Wilcox CM et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 1999; 44: 231-9.
64. Pasricha PJ, Ravich WJ, Hendrix TR et al. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995; 332: 774-8.
65. Eckardt VF, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut 2004; 53: 629-33.
66. Micci MA, Learish RD, Li H et al. Neural stem cells express RET, produce nitric oxide, and survive transplantation in the gastrointestinal tract. Gastroenterology 2001; 121: 757-66.
67. Kahrilas PJ, Dodds WJ, Hogan WJ et al. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 1986; 91: 897-904.
68. Penagini R, Carmagnola S, Cantu P et al. Mechanoreceptors of the proximal stomach: role in triggering transient lower esophageal sphincter relaxation. Gastroenterology 2004; 126: 49-56.
69. Franzi SJ, Martin CJ, Cox MR et al. Response of canine lower esophageal sphincter to gastric distension. Am J Physiol 1990; 259(3 Pt 1): G380-5.
70. Mittal RK, Holloway RH, Penagini R et al. Transient lower esophageal sphincter relaxation. Gastroenterology 1995; 109: 601-10.
71. Sifrim D, Silny J, Holloway RH et al. Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: a study using intraluminal electrical impedance. Gut 1999; 44: 47-54.
72. Sifrim D, Holloway R, Silny J et al. Composition of the postprandial refluxate in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 647-55.
73. Sifrim D, Holloway R, Silny J et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenteroiogy 2001; 120: 1588-98.
74. Pandolfino JE, Shi G, Trueworthy B et al. Esophagogastric junction opening during relaxation distinguishes nonhernia reflux patients, hernia patients, and normal subjects. Gastroenterology 2003; 125: 1018-24.
75. Fletcher J, Wirz A, Young J et al. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 2001; 121: 775-83.
76. Kahrilas PJ. The role of hiatus hernia in GERD. Yale J Biol Med 1999; 72: 101-11.
77. Sloan S, Kahrilas PJ. Impairment of esophageal emptying with hiatal hernia. Gastroenterology 1991; 100: 596-605.
78. Mittal RK, Holloway R, Dent J. Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects. Gastroenterology 1995; 109: 1547-54.
79. Boeckxstaens GE, Hirsch DP, Fakhry N et al. Involvement of cholecystokinin A receptors in transient lower esophageal sphincter relaxations triggered by gastric distension. Am J Gastroenterol 1998; 93: 1823-8.
80. Penagini R, Bianchi PA. Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation. Gastroenterology 1997; 113: 409-14.
81. Hirsch DP, Tytgat GN, Boeckxstaens GE. Is glutamate involved in transient lower esophageal sphincter relaxations? Dig Dis Sci 2002; 47: 661-6.
82. Lehmann A, Blackshaw LA, Branden L et al. Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs. Gastroenterology 2002; 123: 1129-34.
83. Lehmann A, Antonsson M, Bremner-Danielsen M et al. Activation of the GABA(B) receptor inhibits transient lower esophageal sphincter relaxations in dogs. Gastroenterology 1999; 117: 1147-54.
84. Zhang Q, Lehmann A, Rigda R et al. Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002; 50: 19-24.
85. Lidums I, Lehmann A, Checklin H et al. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology 2000; 118: 7-13.
86. Blackshaw LA. Receptors and transmission in the brain-gut axis: potential for novel therapies: IV. GABA(B) receptors in the brain-gastroesophageal axis. Am J Physiol 2001; 281: G311-5.
87. McDermott CM, Abrahams TP, Partosoedarso E et al. Site of action of GABA(B) receptor for vagal motor control of the lower esophageal sphincter in ferrets and rats. Gastroenterology 2001; 120: 1749-62.
88. Smid SD, Young RL, Cooper NJ et al GABA(B)R expressed on vagal afferent neurones inhibit gastric mechanosensitivity in ferret proximal stomach. Am J Physiol 2001; 281: G1494-501.
89. Partosoedarso ER, Young RL, Blackshaw LA. GABA(B) receptors on vagal afferent pathways: peripheral and central inhibition. Am J Physiol 2001; 280: G658-68.
90. Boeckxstaens GE, Tytgat GN. More pathophysiologically oriented treatment of GORD? Lancet 2002; 359: 1267-8.
91. Ireland AC, Holloway RH, Toouli J et al. Mechanisms underlying the antireflux action of fundoplication. Gut 1993; 34: 303-8.
92. Lehman GA. The history and future of implantation therapy for gastroesophageal reflux disease. Gastiointest Endosc Clin N Am 2003; 13: 157-65, xi.
93. Tam WC, Schoeman MN, Zhang Q et al. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease. Gut 2003; 52: 479-85.
94. Corley DA, Katz P, Wo JM et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology 2003; 125: 668-76.
95. Johnson DA, Ganz R, Aisenberg J et al. Endoscopic implantation of Enteryx for treatment of GERD: 12-month results of a prospective, multicenter trial. Am J Gastroenterol 2003; 98: 1921-30.
96. Fockens P. Gatekeeper Reflux Repair System: technique, pre-clinical, and clinical experience. Gastrointest Endosc Clin N Am 2003; 13: 179-89.